benefit risk, quantification, pharma, Drug Safety

Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company.

At the 2014 World Drug Safety Congress Americas Susan Duke, GSK, gave a presentation on “Implementing benefit-risk thinking and quantification into the culture and processes of a large pharmaceutical company.” Download and learn: Benefit-Risk thinking and quantitative evaluation at GSK How it began Where we are now Keeping it simple (unless it’s complex) What are the right questions? Where is …

Download: The impact of AMNOG on benefit assessment and market access in Germany

This presentation entitled “The impact of AMNOG on benefit assessment and market access in Germany”  was given at last year’s Market Access USA conference by Dr Michael Kulig, PhD, MPH, Scientific Advisor, Medical Consultancy Department. Download the presentation to learn: AMNOG Overview (G-BA perspective) Current Issues (G-BA perspective) Patient-relevant endpoints Orphan drugs Existing markets Impact of assessments and resolutions Download …

Download: From Safety Governance to Benefit Risk Governance

At last year’s World Drug Safety Congress Europe, Peter Verdru, MD, Safety Sciences, UCB gave a presentation on “From Safety Governance to Benefit Risk Governance.” Verdru mentions that the continuous safety profile monitoring and benefit risk evaluation of authorised medicinal products is critical to pharmacovigilance processes.  He goes on to discuss in depth, Benefit Risk Teams, Benefit Risk membership, Benefit Risk board …

Download: Presentation ‘The benefit risk mindset & evolving management strategies’

Dr Robin Gellar, Director of Risk Management of Global Pharmacovigilance, Baxter International, spoke at this year's World Drug Safety Congress Americas. I thought you might be interested in downloading his presentation on ‘The benefit risk mindset & evolving management strategies' for free. Download the presentation here. Reasons to download: – A comprehensive review of the PSUR/PBRER in the EU– Learn …

Which #drugsafety experts are speaking at WDSC Europe?

  Speakers confirmed to date for WDSC include experts in drug safety, pharmacovigilance, risk management, signal management, epidemiology, medical information and benefit risk. Production on the World Drug Safety Congress Europe 2012 is going really well with an exceptional speaker panel lined up already. Review the list of experts confirmed to speak at the meeting below who will provide insight …